Source:http://linkedlifedata.com/resource/chebi/id/CHEBI:6950
| Predicate | Object |
|---|---|
| rdf:type | |
| skos:definition |
"A tetracyclic antidepressant that has formula C17H19N3." []
|
| skos:inScheme | |
| skos:prefLabel |
mirtazapine
|
| skos:altLabel |
2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine,
Mirtazapine
|
| skos:notation |
Beilstein:549345 "Beilstein Registry Number",
ChemIDplus:61337-67-5 "CAS Registry Number",
DrugBank:DB00370 "DrugBank",
KEGG COMPOUND:C07570 "KEGG COMPOUND",
KEGG DRUG:D00563 "KEGG DRUG",
Patent:DE2614406 "Patent",
Patent:US4062848 "Patent",
Wikipedia:Mirtazapine "Wikipedia"
|
| skos:broader | |
| skos:relatedSynonym |
mirtazapine,
mirtazapinum,
1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine,
mirtazapina,
C17H19N3,
CN1CCN2C(C1)c1ccccc1Cc1cccnc21,
InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3,
InChIKey=RONZAEMNMFQXRA-UHFFFAOYSA-N
|